Trial Profile
A Retrospective Study to Evaluate the Long Term Efficay and Safety of onabotulinumtoxinA in Patients with Dystonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dystonia
- Focus Adverse reactions; Therapeutic Use
- 20 Aug 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.